How MemoHoney Facts Are Checked on This Website

Memohoney-eng is the U.S. retail partner for MemoHoney, working from 3 Times Square in New York with a separate returns address. It sells the product through the seller’s checkout and writes these pages; it does not make the capsule or choose its formula.

The MemoHoney Team writes the pages. Dr. Sharon Montes, MD, the physician the seller’s pack names, gives each one a medical review. Both are named in the strip at the top of the home page, in the checked-page panel at the foot of every page and on the about page.

• The label artwork for the six named ingredients, the capsule count, the directions and the claim “Advanced Memory Support” with Focus, Clarity and Energy.
• The seller’s page and checkout for packs, prices, postage and the 60-day refund terms. The checkout was read again on 1 October 2026 and still showed $158 for two bottles, $207 for three and $294 for six.
• Public health agencies: the NIH Office of Dietary Supplements, the National Institute on Aging, MedlinePlus, NCCIH, the CDC, the FDA and the FTC.
• Published research found through PubMed. No study has tested MemoHoney itself, and the pages never suggest one has.

The label material this site was given does not print an amount for any ingredient, so no page states one. Where a dose matters, the page gives the amount the research used and says the capsule’s own figure is not on the supplied artwork.

Because the supplied label material gives no amounts, a dose comparison on this site runs in one direction only: it reports what a study used and lets you see the scale. Each comparison names the study by its PMID, the form of the ingredient that study gave (L-citrulline or citrulline malate, for example), the daily amount, how long the study ran and what it measured.

Three habits follow from that. A study in athletes is not presented as evidence about memory. A study that measured blood flow or blood pressure is not presented as evidence of a change in thinking. And a result at several grams a day is never carried over to a capsule without saying how small a capsule is by comparison; the blog piece on what one capsule can actually hold works through that arithmetic.

• MemoHoney is never described as treating, preventing or slowing memory loss, dementia or Alzheimer’s disease.
• The seller’s longer claims, such as boosting neural communication, are quoted as the seller’s and not repeated as facts.
• Seals are explained, never presented as approvals; the FDA does not approve supplements before sale (FDA).
• The four to eight weeks quoted for a first effect is what buyers reported, not a promise.

These limits follow the FTC’s health products guidance and the FDA’s page on structure and function claims.

Scores. The 4.3 average, 1,183 written reviews, 8,833 orders and 90% recommending were handed to this desk by the distributor. They are reproduced as given and labelled as unaudited.

Prices. Set by the seller and shown with the date they were checked. Struck figures ($358, $537, $1,074) are the seller’s comparison prices.

Batch codes. Lot MEM-26/ME-1451 and certificate reference MEM-1451-26-ME are filing references for the stock this desk holds, not lab results.

The editorial score. This desk’s own marks, each printed with its reason, and labelled as opinion.

Send the page address and the line in question to the editorial inbox shown in the footer. For a citation, include the PMID; for a label question, a photograph of your bottle. The desk checks the claim against the source, corrects the page where the error appears and moves its revision date.

September 30, 2026. Bylines and the foot of every page now name the medical reviewer; a doctor-first section was added to the disclaimer; phone and email details moved to the footer and the contact page; the distributor’s score left the top of the home page; the phone menu was fixed so every link can be reached; and this policy was published.